medRxiv preprint doi: https://doi.org/10.1101/2020.07.17.20155218; this version posted April 16, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

ISARIC Clinical Data Report 8 April 2021
International Severe Acute Respiratory and emerging Infections Consortium

ISARIC Clinical Characterisation Group*^
*group members are listed at end of report
^participating institutions are listed at https://isaric.org/research/covid-19-clinical-research-resources/covid-19-data-managementhosting/covid-19-clinical-data-contributors-list/
Correspondence to: Laura.Merson@ndm.ox.ac.uk 1
1 ISARIC, Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK

Abstract
ISARIC (International Severe Acute Respiratory and emerging Infections Consortium) partnerships and outbreak preparedness initiatives
enabled the rapid launch of standardised clinical data collection on COVID-19 in Jan 2020. Extensive global uptake of this resource has
resulted in a large, standardised collection of comprehensive clinical data from hundreds of sites across dozens of countries. Data are
analysed regularly and reported publicly to inform patient care and public health response. This report is a part of a series and includes the
results of data analysis on 8 April 2021.
We thank all of the data contributors for their ongoing support.
Report highlights include:
Data have been entered for 340,312 individuals from 1609 sites across 54 countries.
The analysis detailed in this report only includes individuals:
1. for whom data collection commenced on or before 1 February 2021.
AND
2. who have laboratory-confirmed or clinically-diagnosed SARS-COV-2 infection.
For the 264,496 cases who meet eligibility criteria for this report:
o
o

o
o
o

The median age is 61 years.
The five most common symptoms at admission were shortness of breath, cough, history of fever, fatigue/malaise, and altered
consciousness/confusion. Children and older adults were less likely to display typical symptoms, and around 40% of patients >80
years experienced confusion.
A total of 19% of patients were admitted at some point during their illness into an intensive care unit.
Antibiotic use is high (79.9% of patients received antibiotics - the choice of antibiotic and specific indication have not yet been
determined.)
Altered consciousness/confusion was also relatively frequent (28,190/130,157) and most common in elderly patients. Overall, elderly
patients are less likely to present with URTI symptoms.

To access previous versions of ISARIC COVID-19 Clinical Data Report please use the link below:
https://isaric.org/research/covid-19-clinical-research-resources/evidence-reports/

NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.

ISARIC (International Severe Acute Respiratory and Emerging
Infections Consortium)

A global federation of clinical research networks, providing a proficient, coordinated, and agile research
response to outbreak-prone infectious diseases

COVID-19 Report: 08 April 2021
Containing data extracted 15 February 2021

Summary
The results in this report have been produced using data from the ISARIC COVID-19 database. For
information, or to contribute to the collaboration, please contact ncov@isaric.org.
We thank all of the data contributors for collecting standardised data during these extraordinary times.
We plan to issue this report of aggregate data regularly for the duration of the SARS-CoV-2/COVID-19
pandemic.
Please note the following caveats. This is a dynamic report which captures new variables and information
as our understanding of COVID-19 evolves. Please observe the total number of patients of each result to
note variables with fewer data points. Information is incomplete for the patients who are still being treated.
Furthermore, it is likely that that we received more cases of severely ill individuals than those with relatively
less severe illness; outcomes from these data, such as the proportion dying, must therefore not be used to infer
outcomes for the entire population of people who might become infected. Some patients may be participants
in clinical trials of experimental interventions. Note the variation in patient numbers per country. Additional
caveats are provided in the in the ‘Caveats’ section below.
Up to the date of this report, data have been entered for 340312 individuals from 1609 sites across 54
countries.
The analysis detailed in this report only includes individuals:
1. for whom data collection commenced on or before 1 February 2021. (We have applied a 14-day rule to
focus analysis on individuals who are more likely to have a recorded outcome. By excluding patients
enrolled during the last 14 days, we aim to reduce the number of incomplete data records and thus
improve the generalisability of the results and the accuracy of the outcomes;

1

AND
2. who have laboratory-confirmed SARS-COV-2 infection.
The cohort satisfying the above criteria has 264496 cases. The below flow chart gives an overview of the
cohort and outcomes as of 15 February 2021.

Demographics and presenting features
Of these 264496 cases, 136188 are males and 127692 are females – sex is unreported for 616 cases. The
minimum and maximum observed ages were 0 and 120 years respectively. The median age is 61 years.
The observed mean number of days from (first) symptom onset to hospital admission was 5.2, with a standard
deviation (SD) of 4.9 days and a median of 4 days.
The observed mean duration for the number of days from hospital admission to outcome (death or discharge)
was 10, with SD 9 days and a median of 7 days. These estimates are based on all cases which have complete
records on length of hospital stay (N = 230026).
The observed symptoms on admission partly represent case definitions and policies for hospital admission,
which may change as time passes. The five most common symptoms at admission were shortness of breath,
cough, history of fever, fatigue/malaise, and altered consciousness/confusion. Frequencies of symptom prevalence vary with age. 33586/136988 (24.5%) patients presented with oxygen saturations <94%.

Outcomes
Outcomes have been recorded for 239806 patients (90.7%), consisting of 184010 recoveries and 55796 deaths.
Outcome records are unavailable for 24690 patients.
ICU/HDU: Of the 136337 patients with data on ward admissions available, a total of 31748 (19%) patients
were admitted at some point of their illness into an intensive care unit (ICU) or high dependency unit
(HDU), 50.3% on the day of admission. Of these, 10004 died, and 16180 have recovered and been discharged.
Outcome records are unavailable for 5564 cases.
The distribution of the number of days from admission to ICU admission is shown in Figure 11. The duration
of stay in ICU/HDU had a mean of 10.4 days and a median of 7 (SD: 9.8 days) – estimated on only those
cases with complete records for ICU/HDU duration or ICU/HDU start/end dates (N = 24160).

Treatment
Antibiotics were received by 116265/145463 (79.9%) patients, and 21318/144875 (14.7%) received antivirals.
These treatment categories are not mutually exclusive since some patients received multiple treatments.
(The denominators differ due to data completeness). 97994/158070 (62%) patients received some degree of
oxygen supplementation: of these, 21763/155148 (14%) received NIV and 16915/157115 (10.8%) IMV.
Of the patients admitted into ICU/HDU, 23096/24822 (93%) received antibiotics and 8310/24274 (34.2%)
antivirals. 24631/26211 (94%) received some degree of oxygen supplementation, of which, 12469/25993
(48%) received NIV and 15125/26077 (58%) IMV.
A total of 21763 patients received non-invasive mechanical ventilation (NIV). The mean and median durations
from admission to receiving NIV were 5.8 days and 2 days respectively (SD: 8.3 days) – estimated from records
on cases with complete records on dates of hospital admission and NIV onset (N = 20491). The mean and
median durations for NIV were 3.6 days and 2 days respectively (SD: 3.2 days) – estimated based on only
those cases which have complete NIV duration records (N = 2253).

2

A total of 16915 patients received invasive mechanical ventilation (IMV). The mean and median durations
from admission to receiving IMV were 5 days and 2 days respectively (SD: 7.1 days) – estimated from
records on cases with complete records on dates of hospital admission and IMV onset (N = 15580). The
mean, median and SD for the duration of IMV – estimated based on all 14042 cases with complete records
on IMV stays – were 11 days, 9 days and 9.3 days respectively.
Corticosteroids were administered to 55538/150491 (36.9%) patients. This includes 9057/16255 (55.7%)
of those who received IMV, 36397/78159 (46.6%) of those who had oxygen therapy but not IMV, and
9641/55038 (17.5%) of those who had no oxygen therapy. On 16 June, results for dexamethasone were
released for the RECOVERY randomized controlled trial (RECOVERY, 2020; RECOVERY Collaborative
Group, 2020). This trial found that dexamethasone reduced deaths for patients receiving IMV and oxygen
therapy, but not among patients not receiving respiratory support. Of patients admitted since 16 June,
corticosteroids were received by 4367/5286 (82.6%) of those who received IMV, 27821/34746 (80.1%) of
those who had oxygen therapy but not IMV, and 6983/25675 (27.2%) of those who had no oxygen therapy.

3

Figure 1: Overview of cohort and outcomes as of 15 February 2020.

All patients in ISARIC database
(N=340312)

EXCLUDED 22.3%

<14 follow -up at time of report
(N=640)

ANALYSED 77.7%

>14-days
follow -up and
laboratory-confirmed
SARS-COV-2 infection
(N=264496)

12%

ICU/HDU
(N=31748)

32%
Death
(N=10004)

51%

Discharge
alive (N=16180)

88%
No ICU/HDU or ICU/HDU
status unknow n
(N=232748)

18%
Lost to follow -up
(N=5564)

20%
Death
(N=45792)

4

72%

8%

Discharge
alive (N=167830)

Lost to follow -up
(N=19126)

>14-days
follow -up and
negative or not
confirmed
(N=40885)

Ar
g
Auen
s tin
A tra a
Beust lia
Be la ria
lg rus
i
C Be um
ab B liz
o ra e
V
C er zil
an d
ae
C da
D
C C hile
om
ol hi
om na
in
ic
an CConbia
z
R ec go
e
Ecpu hia
b
Esuadlic
to or
F
G ra nia
er n
m ce
a
G Gha ny
ib n
r
H Grealtaa
H on e r
on d c
g urae
K
In I on s
do nd g
La
ne ia
o
Ire s
Pe
l ia
op
Irland
le Ko
a
's
re
I
sr nd
D
ae
em a, R
oc ep JaItalyl
ra ub pa
tic
li n
R Kuwc of
ep a
ub it
M
M a lic
al law
ay i
N Mexsia
N eth N ic
ew e e o
Zerlanpal
N ala ds
Paorwnd
Sa
ki ay
st
in
a
tV
P Pe n
in
Po ola ru
ce SRus
a
rt n
n
s
Sat anint ian R Qugad
o d Kitt Fe om at l
To th s d a ar
m e Gan era ni
e r d ti a
Ta
an en N on
iw
Sad Pad evi
an
i s
, P Soudi rincnes
ro ut Ar ip
h ab e
vi
nc A ia
e Sfric
of p a
U
ni
Th Chain
te
d
ai ina
l
U Ara Tu and
ni b U rk
te E kr ey
U d Kmi ain
ni i ra e
te ng te
d d s
U Staom
Vi rug tes
et u
N ay
am

5
1
1

3

3

3

7

9
23

20

3899

925
1981

621

6482

3603
1419

430
725

468

461

85

173

4356

6423

397
3750
280
326
801
160
1094
3543

138

86
139

45
60

42

21
13
35

142

1309
3117
3271

913

184347

104022

100000

1
1
1

1
1
1

1

2

1
0
12

100

1

10

1
1

64

1000

14

34

Patient records (pseudo log scale)

Figure 2: Distribution of patients by country

10000

Patient Characteristics
Figure 3: Age and sex distribution of patients. Bar fills are outcome (death/discharge/lost to follow-up
(LTFU)/ongoing care) at the time of report.

Males

Females

90+
80−89
70−79

Outcome

50−59

Death

40−49

Discharge
LTFU

30−39
20−29
10−19

Number of patients

6

25000

20000

15000

10000

5000

0

5000

10000

15000

20000

0−9
25000

Age group

60−69

Figure 4: (a) Frequency of symptoms seen at admission amongst COVID-19 patients. Bars are annotated
with a fraction representing the number of patients presenting with this symptom over the number of patients
for whom presence or absence of this symptom was recorded. (b) The distribution of combinations of the five
most common symptoms, amongst all patients for whom these data were recorded. Filled and empty circles
below the x-axis indicate the presence or absence of each comorbidity. (c) Heatmap for correlation between
symptoms. Fill colour is the phi correlation coeﬀicient for each pair of symptoms, calculated amongst patients
with recorded presence or absence of both.

Symptom

(a)
Shortness of breath
Cough
History of fever
Fatigue/malaise
Altered consciousness/confusion
Muscle aches joint pain
Vomiting/nausea
Diarrhoea
Chest pain
Severe dehydration
Headache
Abdominal pain
Sore throat
Loss of taste
Wheezing
Loss of smell
Runny nose
Skin ulcers
Bleeding
Seizures
Skin rash
Lymphadenopathy
Ear pain
Conjunctivitis

82038 / 143951
81188 / 143969
78649 / 144323
48886 / 129943
28190 / 130157
21529 / 124694
22218 / 135076
20674 / 134614
16281 / 132718
7481 / 62779
12634 / 124595
11735 / 132007
8974 / 121805
6336 / 91733
7687 / 127413
5362 / 93161
3984 / 121099
2069 / 112251
2375 / 131074
1567 / 126122
1489 / 125793
617 / 118258
398 / 108692
443 / 125170

0.00

0.25

0.50

0.75

1.00

Proportion

Proportion of patients

(b)
0.15

0.10

0.05

0.00
Shortness of breath
Cough
History of fever
Fatigue/malaise
Altered consciousness/confusion

Symptoms present at admission

7

Symptom
present
No
Yes

(c)
Altered consciousness / confusion
Seizures
Skin rash
Skin ulcers
Bleeding
Conjunctivitis
Loss of smell
Loss of taste
Lymphadenopathy
Chest pain
Cough
Wheezing
History of fever
Shortness of breath
Headache
Fatigue / Malaise
Muscle aches / Joint pain
Abdominal pain
Vomiting / Nausea
Diarrhoea
Ear pain
Sore throat
Runny nose

phi coefficient
1.0
0.5
0.0
−0.5

Runny nose
Sore throat
Ear pain
Diarrhoea
Vomiting / Nausea
Abdominal pain
Muscle aches / Joint pain
Fatigue / Malaise
Headache
Shortness of breath
History of fever
Wheezing
Cough
Chest pain
Lymphadenopathy
Loss of taste
Loss of smell
Conjunctivitis
Bleeding
Skin ulcers
Skin rash
Seizures
Altered consciousness / confusion

−1.0

8

Figure 5: (a) Frequency of comorbidities or other concomitant conditions seen at admission amongst COVID19 patients. Bars are annotated with a fraction representing the number of patients presenting with this
comorbidity over the number of patients for whom presence or absence of this comorbidity was recorded. (b)
The distribution of combinations of the five most common such conditions, amongst all patients for whom
these data were recorded. Filled and empty circles below the x-axis indicate the presence or absence of each
comorbidity.

Comorbidity

(a)
Hypertension
Diabetes
Chronic cardiac disease
Smoking
Dementia
Obesity
Chronic pulmonary disease
Chronic kidney disease
Chronic neurological disorder
Rheumatologic disorder
Asthma
Malignant neoplasm
Chronic hematologic disease
HIV/AIDS
Severe respiratory conditions
Liver disease
Tuberculosis
On immunosuppression therapies
Malnutrition
Transplantation
Rare diseases and inborn errors of metabolism

0.00

82286 / 196037
64327 / 220884
43787 / 216088
10212 / 68035
17661 / 143023
20791 / 171563
24139 / 215448
24083 / 215217
16560 / 148323
15286 / 142356
22215 / 216572
15464 / 217955
5627 / 142786
7426 / 212419
3294 / 95181
4939 / 154458
2736 / 88767
2450 / 89944
3244 / 139424
823 / 91340
383 / 90420

0.25

0.50

0.75

Proportion

Proportion of patients

(b)
0.4
0.3
0.2
0.1
0.0
Hypertension
Diabetes
Chronic cardiac disease
Dementia
Smoking

Conditions present at admission

9

1.00

Condition
present
No
Yes

Variables by age
Figure 6: Symptoms recorded at hospital presentation stratified by age group. Boxes show the proportion
of individuals with each symptom, with error bars showing 95% confidence intervals. The size of each box is
proportional to the number of individuals represented. N is the number of individuals included in the plot
(this varies between plots due to data completeness)
(b) Dementia

(a) Asthma
N = 216306

(c) Diabetes mellitus

N = 142880

N = 220601

0.50

0.50

0.50

0.25

0.25

0.25

0.00

0.00

0.00

0−9

10−19 20−29 30−39 40−49 50−59 60−69 70−79 80−89 90+
Age group (years)

0−9

10−19 20−29 30−39 40−49 50−59 60−69 70−79 80−89 90+
Age group (years)

(d) Hypertension

0−9

(e) Malignant neoplasm

N = 195794

(f) Obesity

N = 217677

N = 171341

0.50

0.50

0.50

0.25

0.25

0.25

0.00

0.00

0.00

0−9

10−19 20−29 30−39 40−49 50−59 60−69 70−79 80−89 90+
Age group (years)

10−19 20−29 30−39 40−49 50−59 60−69 70−79 80−89 90+
Age group (years)

0−9

10−19 20−29 30−39 40−49 50−59 60−69 70−79 80−89 90+
Age group (years)

(g) Smoking
N = 67981

0.50

0.25

0.00

0−9

10−19 20−29 30−39 40−49 50−59 60−69 70−79 80−89 90+
Age group (years)

10

0−9

10−19 20−29 30−39 40−49 50−59 60−69 70−79 80−89 90+
Age group (years)

Figure 7: Symptoms recorded at hospital presentation stratified by age group. Boxes show the proportion
of individuals with each symptom, with error bars showing 95% confidence intervals. The size of each box is
proportional to the number of individuals represented. N is the number of individuals included in the plot
(this varies between plots due to data completeness).
(a) Abdominal pain

(b) Altered consciousness/confusion

N = 131862

(c) Constitutional symptoms (myalgia,
joint pain, fatigue or headache)

N = 130013

N = 135892

1.00

1.00

1.00

0.75

0.75

0.75

0.50

0.50

0.50

0.25

0.25

0.25

0.00

0.00
0−9

10−19 20−29 30−39 40−49 50−59 60−69 70−79 80−89 90+
Age group (years)

0.00
0−9

10−19 20−29 30−39 40−49 50−59 60−69 70−79 80−89 90+
Age group (years)

(d) Cough

(e) Cough or fever

N = 143817

0−9

(f) Cough, fever or shortness of breath

N = 147355

N = 148719

1.00

1.00

1.00

0.75

0.75

0.75

0.50

0.50

0.50

0.25

0.25

0.25

0.00

0.00
0−9

10−19 20−29 30−39 40−49 50−59 60−69 70−79 80−89 90+
Age group (years)

0.00
0−9

10−19 20−29 30−39 40−49 50−59 60−69 70−79 80−89 90+
Age group (years)

(g) History of fever

(h) Shortness of breath

N = 144172

0−9

N = 143807

N = 124866

1.00

1.00

0.75

0.75

0.75

0.50

0.50

0.50

0.25

0.25

0.25

0.00
0−9

10−19 20−29 30−39 40−49 50−59 60−69 70−79 80−89 90+
Age group (years)

10−19 20−29 30−39 40−49 50−59 60−69 70−79 80−89 90+
Age group (years)

(i) Upper respiratory tract symptoms
(runny nose, sore throat or ear pain)

1.00

0.00

10−19 20−29 30−39 40−49 50−59 60−69 70−79 80−89 90+
Age group (years)

0.00
0−9

10−19 20−29 30−39 40−49 50−59 60−69 70−79 80−89 90+
Age group (years)

(j) Diarrhoea

10−19 20−29 30−39 40−49 50−59 60−69 70−79 80−89 90+
Age group (years)

(k) Vomiting or nausea

N = 134467

N = 134930

1.00

1.00

0.75

0.75

0.50

0.50

0.25

0.25

0.00

0−9

0.00
0−9

10−19 20−29 30−39 40−49 50−59 60−69 70−79 80−89 90+
Age group (years)

0−9

11

10−19 20−29 30−39 40−49 50−59 60−69 70−79 80−89 90+
Age group (years)

Figure 8: Box and whisker plots for observations at hospital presentation stratified by age group. Outliers
are omitted. N is the number of individuals included in the plot (this varies between plots due to data
completeness).
(a) Respiratory rate

(b) Heart rate

N = 133789

N = 138964

30

Heart rate (min)

Respiratory rate (min)

120

20

90

60

10

0−9

10−19

20−29

30−39

40−49

50−59

60−69

70−79

80−89

90+

0−9

10−19

20−29

30−39

Age groups

40−49

50−59

60−69

70−79

80−89

90+

70−79

80−89

90+

Age groups

(c) Temperature

(d) Systolic blood pressure

N = 148481

N = 145661

Systolic blood pressure (mmHg)

38

36

0−9

10−19

20−29

30−39

40−49

50−59

60−69

70−79

80−89

150

100

90+

0−9

10−19

20−29

30−39

Age groups

40−49

50−59

Age groups

(e) Oxygen saturation
N = 136850
100

98

Oxygen saturation in room air (%)

Temperature (Celsius)

40

96

94

92

90

88

86

0−9

10−19

20−29

30−39

40−49

50−59

Age groups

12

60−69

70−79

80−89

90+

60−69

Figure 9: Box and whisker plots for laboratory results within 24 hours of hospital presentation stratified by
age group. Outliers are omitted. N is the number of individuals included in the plot (this varies between
plots due to data completeness).
(a) Alanine transaminase (ALT)

(b) Aspartate transaminase (AST)

N = 62273

N = 15860
120

75

AST (units/L)

ALT (units/L)

90
50

25

60

30

0

0
0−9

10−19

20−29

30−39

40−49

50−59

60−69

70−79

80−89

90+

0−9

10−19

20−29

30−39

Age groups

40−49

50−59

60−69

70−79

80−89

90+

Age groups

(c) Bilirubin

(d) Activated partial thromboplastin time (APTT)

N = 66105

N = 1006
50

15

APTT (s)

Bilirubin (mmol/L)

20

10

40

30

5
20
0
0−9

10−19

20−29

30−39

40−49

50−59

60−69

70−79

80−89

90+

0−9

10−19

20−29

30−39

Age groups

40−49

50−59

60−69

70−79

80−89

90+

60−69

70−79

80−89

90+

60−69

70−79

80−89

90+

80−89

90+

Age groups

(e) Protrombin time

(f) Urea

N = 45827

N = 80667

20

Urea (mmol/L)

Protrombin time (s)

20

15

10

15

10

5

0
0−9

10−19

20−29

30−39

40−49

50−59

60−69

70−79

80−89

90+

0−9

10−19

20−29

30−39

Age groups

40−49

50−59

Age groups

(g) White blood cell count (WCC)

(h) Neutrophils

N = 93464

N = 86636
15

Neutrophils (10^9/L)

WBC (10^9/L)

15

10

5

0

10

5

0
0−9

10−19

20−29

30−39

40−49

50−59

60−69

70−79

80−89

90+

0−9

10−19

20−29

30−39

Age groups

40−49

50−59

Age groups

(i) Lymphocytes

(j) C-reactive protein (CRP)

N = 85544

N = 94682

2

CRP (mg/L)

Lymphocytes (10^9/L)

300

1

13

0
0−9

10−19

20−29

30−39

40−49

50−59

Age groups

60−69

70−79

80−89

90+

200

100

0

0−9

10−19

20−29

30−39

40−49

50−59

Age groups

60−69

70−79

Hospital stays and outcomes
Figure 10: Distribution of length of hospital stay, according to sex. This only includes cases with reported
outcomes. The coloured areas indicate the kernel probability density of the observed data and the box plots
show the median and interquartile range of the variable of interest.

50

Length of hospital stay

40

30

Sex
Male
Female

20

10

0
Male

Female

Sex

14

Figure 11: Distribution of length of hospital stay, according to patient age group. This only includes cases
with reported outcomes. The coloured areas indicate the kernel probability density of the observed data and
the box plots show the median and interquartile range of the variable of interest.

50

Age

Length of hospital stay

40

0−9
10−19
30

20−29
30−39
40−49

20

50−59
60−69
10

70+

0
0−9

10−19

20−29

30−39

40−49

50−59

60−69

70+

Age group

Figure 12: Distribution of time (in days) from hospital admission to ICU admission. The figure displays
data on only those cases with a reported ICU start date.

0.5

Density

0.4

0.3

0.2

0.1

0.0
0

1

2

3

4

5

6

7

8

9

10 11 12 13 14 15 16 17 18 19 20

Time (in days) from admission to ICU
15

Figure 13: The distribution of patient status by number of days after admission. Patients with ’unknown’
status have left the site at the time of report but have unknown outcomes due to missing data. The black
line marks the end of 14 days.

1.00

0.75

Proportion

Status
Discharged
Unknown
0.50

Ward
ICU
Death

0.25

0.00
0

10

20

30

Days relative to admission

16

40

50

2019−49
2019−50
2019−51
2019−52
2020−1
2020−2
2020−3
2020−4
2020−5
2020−6
2020−7
2020−8
2020−9
2020−10
2020−11
2020−12
2020−13
2020−14
2020−15
2020−16
2020−17
2020−18
2020−19
2020−20
2020−21
2020−22
2020−23
2020−24
2020−25
2020−26
2020−27
2020−28
2020−29
2020−30
2020−31
2020−32
2020−33
2020−34
2020−35
2020−36
2020−37
2020−38
2020−39
2020−40
2020−41
2020−42
2020−43
2020−44
2020−45
2020−46
2020−47
2020−48
2020−49
2020−50
2020−51
2020−52
2020−53

Cumulative patient records

Figure 14: Cumulative patient numbers and outcomes by epidemiological week (of 2020) of admission (or,
for patients infected in hospital, of symptom onset).

200000

150000

Outcome
Death

100000
Discharge

LTFU

50000

0

Epidemiological week of admission/symptom onset

17

Treatment
Figure 15: (a) Treatments used. This only includes patients for whom this information was recorded. (b)
The distribution of combinations of antimicrobial treatments and steroids administered during hospital stay,
across all patients with completed hospital stay and recorded treatment data.

Treatment

(a)
Antibiotic agents
Nasal mask oxygen therapy
Corticosteroids
High flow nasal cannula
Other interventions
Antiviral agents
Non invasive ventilation
Neuromuscular blocking agents
Prone positioning
Invasive ventilation
Inotropes/vasopressors
Prone ventilation
Agents acting on the renin angiotensin system
Antifungal agents
Hemofiltration
Off label compassionate use medications
Tracheostomy
Convalescent plasma
Extracorporeal
Interleukin inhibitors
Inhaled nitric oxide

0.00

116265 / 145463
92129 / 150741
55538 / 150491
30637 / 136693
6267 / 39072
21318 / 144875
21763 / 155148
4401 / 38160
5382 / 48208
16915 / 157115
11522 / 149465
9834 / 142168
9066 / 148911
7492 / 146810
1483 / 35387
3034 / 91149
3478 / 144705
1849 / 87937
1049 / 155117
546 / 87429
677 / 138961

0.25

0.50

0.75

1.00

Proportion

Proportion of patients

(b)
0.15

0.10

0.05

0.00
Antibiotic agents
Nasal mask oxygen therapy
Corticosteroids
High flow nasal cannula
Other interventions

Treatments used during hospital admission

18

Treatment
received
No
Yes

Intensive Care and High Dependency Unit Treatments
Figure 16: (a) Treatments used amongst patients admitted to the ICU. This only includes patients for whom
this information was recorded. (b) The distribution of combinations of treatments administered during
ICU/HDU stay. Filled and empty circles below the x-axis indicate treatments that were and were not
administered respectively. (c) Distribution of lengths of stay for patients who were admitted to ICU/HDU:
total length of stay for this group and length of stay within intensive care. This only includes cases with
reported completed stays. The coloured areas indicate the kernel probability density of the observed data
and the box plots show the median and interquartile range of the variable of interest.

Treatment

(a)
Antibiotic agents
Nasal mask oxygen therapy
Therapeutic anticoagulant
Invasive ventilation
Corticosteroids
Non invasive ventilation
Inotropes/vasopressors
High flow nasal cannula
Prone ventilation
Prone positioning
Neuromuscular blocking agents
Antiviral agents
Other interventions
Agents acting on the renin angiotensin system
Hemofiltration
Antifungal agents
Tracheostomy
Immunosuppressants
Non steroidal anti inflammatory
Convalescent plasma
Off label compassionate use medications
Extracorporeal
Interleukin inhibitors
Inhaled nitric oxide

0.00

23096 / 24822
21267 / 24637
4360 / 6243
15125 / 26077
13737 / 24737
12469 / 25993
10742 / 24593
9789 / 22946
8474 / 21828
4718 / 12573
4137 / 11681
8310 / 24274
2886 / 11550
4492 / 24331
1134 / 8084
3243 / 23456
3136 / 22957
433 / 3659
470 / 5119
671 / 10258
573 / 9840
868 / 25908
310 / 9924
604 / 21917

0.25

0.50

0.75

Proportion

(b)
Proportion of patients

0.20
0.15
0.10
0.05
0.00
Antibiotic agents
Nasal mask oxygen therapy
Invasive ventilation
Corticosteroids
Therapeutic anticoagulant

Treatments used

19

1.00

Treatment
received
No
Yes

(c)
50

Length of stay (days)

40

30

20

10

0
Total hospital stay

ICU

Location

20

Background
In response to the emergence of novel coronavirus (COVID-19), ISARIC launched a portfolio of resources
to accelerate outbreak research and response. These include data collection, analysis and presentation tools
which are freely available to all sites which have requested access to these resources. All data collection
tools are designed to address the most critical public health questions, have undergone extensive review by
international clinical experts, and are free for all to use. Resources are available on the ISARIC website.
The ISARIC-WHO COVID-19 Case Record Form (CRF) enables the collection of standardised clinical data
to inform patient management and public health response. These forms should be used to collect data on
suspected or confirmed cases of COVID-19. The CRF is available in multiple languages and is now in use
across dozens of countries and research consortia, who are contributing data to these reports.
To support researchers to retain control of the data and samples they collect, ISARIC also hosts a data
platform, where data can be entered to a web-based REDCap data management system, securely stored,
and used to produce regular reports on their sites as above. Data contributors are invited to input on
the methods and contents of the reports, and can also contribute to the aggregated data platform which
aggregates site-specific data from all other sites across the world who are using this system. For more
information, visit the ISARIC website.
All decisions regarding data use are made by the institutions that enter the data. ISARIC keeps contributors
informed of any plans and welcomes their input to promote the best science and the interests of patients,
institutions and public health authorities. Feedback and suggestions are welcome at ncov@isaric.org.

Methods
Patient details were submitted electronically by participating sites to the ISARIC database. Relevant background and presenting symptoms were recorded on the day of study recruitment. Daily follow-up was then
completed until recovery or death. A final form was completed with details of treatments received and outcomes. All categories that represent fewer than five individuals have been suppressed to avoid the potential
for identification of participants.
Graphs have been used to represent the age distribution of patients by sex and status (dead, recovered & still
in hospital), the prevalence of individual symptoms on admission, comorbidities on admission, the length
of hospital stay by sex and age group and the distribution of patient statuses by time since admission. In
addition, the number of cases recruited by country and site, as well as the case count by status, has been
represented.
All analysis were performed using the R statistical software (R Core Team, 2019).

Caveats
Patient data are collected and uploaded from start of admission, however a complete patient data set is not
available until the episode of care is complete. This causes a predictable lag in available data influenced by
the duration of admission which is greatest for the sickest patients, and accentuated during the up-phase of
the outbreak.
These reports provide regular outputs from the ISARIC COVID-19 database. We urge caution in interpreting
unexpected results. We have noted some unexpected results in the report, and are working with sites that
submitted data to gain a greater understanding of these.

Acknowledgements
This report is made possible through the efforts and expertise of the staff collecting data at our partner
institutions across the globe, and the ISARIC Team. For a list of partners and team members, please visit
21

https://isaric.org/research/covid-19-clinical-research-resources/covid-19-data-management-hosting/covid19-clinical-data-contributors-list/.

References
Docherty, A.B., E.M. Harrison, C.A. Green, H.E. Hardwick, R. Pius, L. Norman, et al.. (2020). Features of
20 133 UK patients in hospital with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol:
prospective observational cohort study. BMJ, 369: m1985. doi: 10.1136/bmj.m1985
R Core Team (2019). R: A language and environment for statistical computing. R Foundation for Statistical
Computing, Vienna, Austria.
RECOVERY (2020, 16 June). Low-cost dexamethasone reduces death by up to one third in hospitalised
patients with severe respiratory complications of COVID-19. https://www.recoverytrial.net/news/lowcost-dexamethasone-reduces-death-by-up-to-one-third-in-hospitalised-patients-with-severe-respiratorycomplications-of-covid-19
RECOVERY Collaborative Group (2020). Dexamethasone in hospitalized patients with Covid-19 — preliminary report. New England Journal of Medicine doi: 10.1056/NEJMoa2021436

Summary tables

22

Table 1: Patient Characteristics. Proportions are presented in parentheses, and have been rounded to two
decimal places.
Description

value

Size of cohort

264496

By sex
Female

127692 (0.48)

Male

136188 (0.51)

Unknown

616 (0)

By outcome status
Death

55796 (0.21)

Discharge

184010 (0.7)

LTFU

24690 (0.09)

By age group
0-9

3354 (0.01)

10-19

4153 (0.02)

20-29

13728 (0.05)

30-39

24986 (0.09)

40-49

32372 (0.12)

50-59

45243 (0.17)

60-69

42918 (0.16)

70+

95715 (0.36)

Unknown

2027 (0.01)

Admitted to ICU/HDU?
No

122284 (0.46)

Unknown

110464 (0.42)

Yes

31748 (0.12)

23

Table 2: Outcome by age and sex. Proportions are calculated using the column total as the denominator.
Death

Discharge

LTFU

0-9

90 (0)

3010 (0.02)

254 (0.01)

10-19

80 (0)

3648 (0.02)

425 (0.02)

20-29

386 (0.01)

12095 (0.07)

1247 (0.05)

30-39

1230 (0.02)

21782 (0.12)

1974 (0.08)

40-49

2821 (0.05)

26931 (0.15)

2620 (0.11)

50-59

6479 (0.12)

34852 (0.19)

3912 (0.16)

60-69

10050 (0.18)

28734 (0.16)

4134 (0.17)

70+

34223 (0.62)

51604 (0.28)

9888 (0.4)

Female

23335 (0.42)

93000 (0.51)

11357 (0.46)

Male

32253 (0.58)

90691 (0.49)

13244 (0.54)

Variable
Age

Sex

24

Table 3: Prevalence of symptoms.
Symptoms

Present

Absent

Unknown

Shortness of breath

82038 (0.31)

61913 (0.23)

120545 (0.46)

Cough

81188 (0.31)

62781 (0.24)

120527 (0.46)

History of fever

78649 (0.3)

65674 (0.25)

120173 (0.45)

Fatigue/malaise

48886 (0.18)

81057 (0.31)

134553 (0.51)

Altered consciousness/confusion

28190 (0.11)

101967 (0.39)

134339 (0.51)

Vomiting/nausea

22218 (0.08)

112858 (0.43)

129420 (0.49)

Muscle aches joint pain

21529 (0.08)

103165 (0.39)

139802 (0.53)

Diarrhoea

20674 (0.08)

113940 (0.43)

129882 (0.49)

Chest pain

16281 (0.06)

116437 (0.44)

131778 (0.5)

Headache

12634 (0.05)

111961 (0.42)

139901 (0.53)

Abdominal pain

11735 (0.04)

120272 (0.45)

132489 (0.5)

Sore throat

8974 (0.03)

112831 (0.43)

142691 (0.54)

Wheezing

7687 (0.03)

119726 (0.45)

137083 (0.52)

Severe dehydration

7481 (0.03)

55298 (0.21)

201717 (0.76)

Loss of taste

6336 (0.02)

85397 (0.32)

172763 (0.65)

Loss of smell

5362 (0.02)

87799 (0.33)

171335 (0.65)

Runny nose

3984 (0.02)

117115 (0.44)

143397 (0.54)

Bleeding

2375 (0.01)

128699 (0.49)

133422 (0.5)

Skin ulcers

2069 (0.01)

110182 (0.42)

152245 (0.58)

Seizures

1567 (0.01)

124555 (0.47)

138374 (0.52)

Skin rash

1489 (0.01)

124304 (0.47)

138703 (0.52)

Lymphadenopathy

617 (0)

117641 (0.44)

146238 (0.55)

Conjunctivitis

443 (0)

124727 (0.47)

139326 (0.53)

Ear pain

398 (0)

108294 (0.41)

155804 (0.59)

25

Table 4: Prevalence of comorbidities.
Comorbidities

Present

Absent

Unknown

Hypertension

82286 (0.31)

113751 (0.43)

68459 (0.26)

Diabetes

64327 (0.24)

156557 (0.59)

43612 (0.16)

Chronic cardiac disease

43787 (0.17)

172301 (0.65)

48408 (0.18)

Chronic pulmonary disease

24139 (0.09)

191309 (0.72)

49048 (0.19)

Chronic kidney disease

24083 (0.09)

191134 (0.72)

49279 (0.19)

Asthma

22215 (0.08)

194357 (0.73)

47924 (0.18)

Obesity

20791 (0.08)

150772 (0.57)

92933 (0.35)

Dementia

17661 (0.07)

125362 (0.47)

121473 (0.46)

Chronic neurological disorder

16560 (0.06)

131763 (0.5)

116173 (0.44)

Malignant neoplasm

15464 (0.06)

202491 (0.77)

46541 (0.18)

Rheumatologic disorder

15286 (0.06)

127070 (0.48)

122140 (0.46)

Smoking

10212 (0.04)

57823 (0.22)

196461 (0.74)

HIV/AIDS

7426 (0.03)

204993 (0.78)

52077 (0.2)

Chronic hematologic disease

5627 (0.02)

137159 (0.52)

121710 (0.46)

Liver disease

4939 (0.02)

149519 (0.57)

110038 (0.42)

Severe respiratory conditions

3294 (0.01)

91887 (0.35)

169315 (0.64)

Malnutrition

3244 (0.01)

136180 (0.51)

125072 (0.47)

Tuberculosis

2736 (0.01)

86031 (0.33)

175729 (0.66)

On immunosuppression therapies

2450 (0.01)

87494 (0.33)

174552 (0.66)

Transplantation

823 (0)

90517 (0.34)

173156 (0.65)

Rare diseases and inborn errors of metabolism

383 (0)

90037 (0.34)

174076 (0.66)

26

Table 5: Treatment use. The counts presented for treatments include all cases, not only cases with complete
details of treatments (as expressed in the summary).
Treatments

Present

Absent

Unknown

Antibiotic agents

116265 (0.44)

29198 (0.11)

119033 (0.45)

Nasal mask oxygen therapy

92129 (0.35)

58612 (0.22)

113755 (0.43)

Corticosteroids

55538 (0.21)

94953 (0.36)

114005 (0.43)

High flow nasal cannula

30637 (0.12)

106056 (0.4)

127803 (0.48)

Non invasive ventilation

21763 (0.08)

133385 (0.5)

109348 (0.41)

Antiviral agents

21318 (0.08)

123557 (0.47)

119621 (0.45)

Invasive ventilation

16915 (0.06)

140200 (0.53)

107381 (0.41)

Inotropes/vasopressors

11522 (0.04)

137943 (0.52)

115031 (0.43)

Prone ventilation

9834 (0.04)

132334 (0.5)

122328 (0.46)

Agents acting on the renin angiotensin system

9066 (0.03)

139845 (0.53)

115585 (0.44)

Antifungal agents

7492 (0.03)

139318 (0.53)

117686 (0.44)

Other interventions

6267 (0.02)

32805 (0.12)

225424 (0.85)

Prone positioning

5382 (0.02)

42826 (0.16)

216288 (0.82)

Neuromuscular blocking agents

4401 (0.02)

33759 (0.13)

226336 (0.86)

Tracheostomy

3478 (0.01)

141227 (0.53)

119791 (0.45)

Off label compassionate use medications

3034 (0.01)

88115 (0.33)

173347 (0.66)

Convalescent plasma

1849 (0.01)

86088 (0.33)

176559 (0.67)

Hemofiltration

1483 (0.01)

33904 (0.13)

229109 (0.87)

Extracorporeal

1049 (0)

154068 (0.58)

109379 (0.41)

Inhaled nitric oxide

677 (0)

138284 (0.52)

125535 (0.47)

Interleukin inhibitors

546 (0)

86883 (0.33)

177067 (0.67)

27

Table 6: Key time variables. SD: Standard deviation; IQR: Interquartile range. Outliers (values greater
than 120) were excluded prior to the computation of estimates.
Time (in days)

Mean (observed)

SD (observed)

Median (observed)

IQR (observed)

10.2

9.2

8

10

Symptom onset to admission

5.2

4.9

4

7

Admission to ICU entry

1.5

2.4

0

2

10.4

9.8

7

12

5.0

7.1

2

6

11.0

9.3

9

13

Admission to NIV

5.8

8.3

2

8

Duration of NIV

3.6

3.2

2

4

Length of hospital stay

Duration of ICU

Admission to IMV
Duration of IMV

28

medRxiv preprint doi: https://doi.org/10.1101/2020.07.17.20155218; this version posted April 16, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

ISARIC Clinical Characterisation Group
Abdukahil, Sheryl Ann; Abdulkadir, Nurul Najmee; Abe, Ryuzo; Abel, Laurent; Absil, Lara;
Acharya, Subhash; Acker, Andrew; Adachi, Shingo; Adam, Elisabeth; Adrião, Diana; Ageel,
Saleh Al; Ain, Quratul; Ainscough, Kate; Ait Hssain, Ali; Ait Tamlihat, Younes; Akimoto, Takako;
Akmal, Ernita; Al Qasim, Eman; Al-dabbous, Tala; Al-Fares, Abdulrahman; Alalqam, Razi; Alam,
Tanvir; Alegre, Cynthia; Alessi, Marta; Alex, Beatrice; Alexandre, Kévin; Alfoudri, Huda; Ali
Shah, Naseem; Alidjnou, Kazali Enagnon; Aliudin, Jeffrey; Allavena, Clotilde; Allou, Nathalie;
Altaf, Aneela; Alves, João; Alves, João Melo; Alves, Rita; Amaral, Maria; Amira, Nur;
Ammerlaan, Heidi; Ampaw, Phoebe; Andini, Roberto; Andrejak, Claire; Angheben, Andrea;
Angoulvant, François; Ansart, Séverine; Anthonidass, Sivanesen; Antonelli, Massimo; Antunes
de Brito, Carlos Alexandre; Apriyana, Ardiyan; Arabi, Yaseen; Aragao, Irene; Arali, Rajeshwari;
Arancibia, Francisco; Arcadipane, Antonio; Archambault, Patrick; Arenz, Lukas; Arie Zainul,
Fatoni; Arlet, Jean-Benoît; Arnold-Day, Christel; Aroca, Ana; Arora, Lovkesh; Arora, Rakesh;
Artaud-Macari, Elise; Aryal, Diptesh; Asaki, Motohiro; Asensio, Angel; Ashley, Elizabeth;
Ashraf, Muhammad; Assie, Jean Baptiste; Asyraf, Amirul; Atique, Anika; Attanyake, AM Udara
Lakshan; Auchabie, Johann; Aumaitre, Hugues; Auvet, Adrien; Azemar, Laurène; Azoulay,
Cecile; Bach, Benjamin; Bachelet, Delphine; Badr, Claudine; Baillie, J. Kenneth; Bak, Erica;
Bakakos, Agamemnon; Bakar, Nazreen Abu; Bal, Andriy; Balakrishnan, Mohanaprasanth;
Banheiro, Bruno; Bani-Sadr, Firouzé; Barbalho, Renata; Barclay, Wendy S.; Barnett, Saef
Umar; Barnikel, Michaela; Barrasa, Helena; Barrelet, Audrey; Barrigoto, Cleide; Bartoli, Marie;
Bartone, Cheryl; Baruch, Joaquín; Basmaci, Romain; Basri, Muhammad Fadhli Hassin; Bastos,
Diego; Battaglini, Denise; Bauer, Jules; Bautista, Diego; Bazan Dow, Denisse; Beane, Abigail;
Bedossa, Alexandra; Bee, Ker Hong; Behilill, Sylvie; Beishuizen, Albertus; Beljantsev,
Aleksandr; Bellemare, David; Beltrame, Anna; Beluze, Marine; Benech, Nicolas; Benjiman,
Lionel Eric; Benkerrou, Dehbia; Bennett, Suzanne; Bento, Luís; Berdal, Jan-Erik; Bergeaud,
Delphine; Bernal Salvador, Gabriela; Bernal Sobrino, José Luis; Bertolino, Lorenzo; Bessis,
Simon; Betz, Adam; Bevilcaqua, Sybille; Bezulier, Karine; Bhatt, Amar; Bhavsar, Krishna;
Bianchi, Isabella; Bianco, Claudia; Bidin, Farah Nadiah; Bikram Singh, Moirangthem; Bin
Humaid, Felwa; Bin Kamarudin, Mohd Nazlin; Bissuel, François; Biston, Patrick; Bitker,
Laurent; Blanco-Schweizer, Pablo; Blier, Catherine; Bloos, Frank; Blot, Mathieu; Blumberg,
Lucille; Boccia, Filomena; Bodenes, Laetitia; Bogaarts, Alice; Bogaert, Debby; Boivin, AnneHélène; Bolze, Pierre-Adrien; Bompart, François; Booth, Gareth; Borges, Diogo; Borie,
Raphaël; Bosse, Hans Martin; Botelho-Nevers, Elisabeth; Bouadma, Lila; Bouchaud, Olivier;
Bouchez, Sabelline; Bouhmani, Dounia; Bouhour, Damien; Bouiller, Kévin; Bouillet, Laurence;
Bouisse, Camile; Boureau, Anne-Sophie; Bouscambert, Maude; Bousquet, Aurore; Bouziotis,
Jason; Boxma, Bianca; Boyer-Besseyre, Marielle; Boylan, Maria; Bozza, Fernando; Brack,
Matthew; Braconnier, Axelle; Braga, Cynthia; Brandenburger, Timo; Brás Monteiro, Filipa;
Brazzi, Luca; Breen, Dorothy; Breen, Patrick; Brickell, Kathy; Broadley, Tessa; Browne, Alex;
Brozzi, Nicolas; Buchtele, Nina; Buesaquillo, Christian; Bugaeva, Polina; Buisson, Marielle;
Burhan, Erlina; Burrell, Aidan; Bustos, Ingrid G.; Butnaru, Denis; Cabie, André; Cabral, Susana;
Caceres, Eder; Cadoz, Cyril; Callahan, Mia; Calligy, Kate; Calvache, Jose Andres; Camões, João;
Campana, Valentine; Campbell, Paul; Canepa, Cecilia; Cantero, Mireia; Caraux-Paz, Pauline;
Cárcel, Sheila; Cardellino, Chiara; Cardoso, Filipa; Cardoso, Filipe; Cardoso, Nelson; Cardoso,
Sofia; Carelli, Simone; Carlier, Nicolas; Carmoi, Thierry; Carney, Gayle; Carpenter, Chloe;
Carret, Marie-Christine; Carrier, François Martin; Carson, Gail; Casanova, Maire-Laure;
Cascão, Mariana; Casimiro, José; Cassandra, Bailey; Castañeda, Silvia; Castanheira, Nidyanara;

medRxiv preprint doi: https://doi.org/10.1101/2020.07.17.20155218; this version posted April 16, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

Castor-Alexandre, Guylaine; Castrillón, Henry; Castro, Ivo; Catarino, Ana; Catherine, FrançoisXavier; Cavalin, Roberta; Cavalli, Giulio Giovanni; Cavayas, Alexandros; Ceccato, Adrian;
Cervantes-Gonzalez, Minerva; Chair, Anissa; Chakveatze, Catherine; Chan, Adrienne; Chand,
Meera; Chantalat Auger, Christelle; Chapplain, Jean-Marc; Chas, Julie; Chaudary, Mobin;
Chávez Iñiguez, Jonathan Samuel; Chen, Anjellica; Chen, Yih-Sharng; Cheng, Matthew Pellan;
Cheret, Antoine; Chiarabini, Thibault; Chica, Julian; Chidambaram, Suresh Kumar; Chirouze,
Catherine; Chiumello, Davide; Cho, Hwa Jin; Cho, Sung Min; Cholley, Bernard; Chopin, MarieCharlotte; Chow, Ting Soo; Chow, Yock Ping; Chua, Hiu Jian; Chua, Jonathan; Cidade, Jose
Pedro; Cisneros Herreros, Jose Miguel; Citarella, Barbara Wanjiru; Ciullo, Anna; Clarke,
Jennifer; Clohisey, Sara; Coca, Necsoi; Codan, Cassidy; Cody, Caitriona; Coelho, Alexandra;
Colin, Gwenhaël; Collins, Michael; Colombo, Sebastiano Maria; Combs, Pamela; Connor,
Marie; Conrad, Anne; Contreras, Sofía; Conway, Elaine; Cooke, Graham S.; Copland, Mary;
Cordel, Hugues; Corley, Amanda; Cormican, Sarah; Cornelis, Sabine; Cornet, Alexander Daniel;
Corpuz, Arianne Joy; Cortegiani, Andrea; Corvaisier, Grégory; Couffignal, Camille; CouffinCadiergues, Sandrine; Courtois, Roxane; Cousse, Stéphanie; Crepy D'Orleans, Charles;
Croonen, Sabine; Crowl, Gloria; Crump, Jonathan; Cruz, Claudina; Cruz Bermúdez, Juan Luis;
Cruz Rojo, Jaime; Csete, Marc; Cucino, Alberto; Cullen, Caroline; Cummings, Matthew; Curley,
Gerard; Curlier, Elodie; Custodio, Paula; D'Amico, Federico; D'Aragon, Frédérick; D'Ortenzio,
Eric; da Silva Filipe, Ana; Da Silveira, Charlene; Dabaliz, Al-Awwab; Dalton, Heidi; Daneman,
Nick; Daniel, Corinne; Dankwa, Emmanuelle; Dantas, Jorge; Dantas, Vicente; de Boer, Mark;
de Mendoza, Diego; De Montmollin, Etienne; de Oliveira França, Rafael Freitas; de Pinho
Oliveira, Ana Isabel; De Rosa, Rosanna; de Silva, Thushan; De vries, Peter; Deacon, Jillian;
Dean, David; Debard, Alexa; Debray, Marie-Pierre; DeCastro, Nathalie; Dechert, William;
Deconninck, Lauren; Decours, Romain; Defous, Eve; Delacroix, Isabelle; Delaneuve, Eric;
Delavigne, Karen; Delfos, Nathalie M.; Deligiannis, Ionna; Dell'Amore, Andrea; Delmas,
Christelle; Delobel, Pierre; Demonchy, Elisa; Denis, Emmanuelle; Deplanque, Dominique;
Depuydt, Pieter; Desai, Mehul; Descamps, Diane; Desvallée, Mathilde; Dewayanti, Santi;
Diallo, Alpha; Diamantis, Sylvain; Dias, André; Diaz, Juan Jose; Diaz, Priscila; Diaz, Rodrigo;
Didier, Kévin; Diehl, Jean-Luc; Dieperink, Wim; Dimet, Jérôme; Dinot, Vincent; Diop, Fara;
Diouf, Alphonsine; Dishon, Yael; Djossou, Félix; Docherty, Annemarie B.; Dondorp, Arjen M;
Dong, Andy; Donnelly, Christl A.; Donnelly, Maria; Donohue, Chloe; Dorival, Céline; Doshi,
Yash; Doshi, Yash; Douglas, James Joshua; Douma, Renee; Dournon, Nathalie; Downer,
Triona; Downing, Mark; Drake, Tom; Driscoll, Aoife; Dryden, Murray; Duarte Fonseca, Claudio;
Dubee, Vincent; Dubos, François; Ducancelle, Alexandre; Duculan, Toni; Dudman, Susanne;
Dunand, Paul; Dunning, Jake; Duplaix, Mathilde; Durante Mangoni, Emanuele; Durham III,
Lucian; Dussol, Bertrand; Duthoit, Juliette; Duval, Xavier; Dyrhol-Riise, Anne Margarita; Ean,
Sim Choon; Echeverria-Villalobos, Marco; Egan, Siobhan; Eira, Carla; El Sanharawi,
Mohammed; Elapavaluru, Subbarao; Elharrar, Brigitte; Ellerbroek, Jacobien; Ellis, Rachael;
Eloy, Philippine; Elshazly, Tarek; Enderle, Isabelle; Eng, Chan Chee; Engelmann, Ilka; Enouf,
Vincent; Epaulard, Olivier; Escher, Martina; Esperatti, Mariano; Esperou, Hélène; EspositoFarese, Marina; Estevão, João; Etienne, Manuel; Ettalhaoui, Nadia; Everding, Anna Greti;
Evers, Mirjam; Fabre, Isabelle; Fabre, Marc; Faheem, Amna; Fahy, Arabella; Fairfield,
Cameron J.; Faria, Pedro; Farooq, Ahmed; Farshait, Nataly; Fateena, Hanan; Faure, Karine;
Favory, Raphaël; Fayed, Mohamed; Feely, Niamh; Fernandes, Jorge; Fernandes, Marília;
Fernandes, Susana; Ferrand, François-Xavier; Ferrand Devouge, Eglantine; Ferrão, Joana;
Ferraz, Mário; Ferreira, Benigno; Ferrer-Roca, Ricard; Ferriere, Nicolas; Ficko, Céline;
Figueiredo-Mello, Claudia; Fiorda, Juan; Flament, Thomas; Flateau, Clara; Fletcher, Tom;

medRxiv preprint doi: https://doi.org/10.1101/2020.07.17.20155218; this version posted April 16, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

Florio, Letizia Lucia; Flynn, Brigid; Foley, Claire; Fomin, Victor; Fonseca, Tatiana; Fontela,
Patricia; Forsyth, Simon; Foster, Denise; Foti, Giuseppe; Fourn, Erwan; Fowler, Robert A.;
Fraher, Dr Marianne; Franch-Llasat, Diego; Fraser, Christophe; Fraser, John F.; Freire, Marcela
Vieira; Freitas Ribeiro, Ana; Friedrich, Caren; Fritz, Ricardo; Fry, Stéphanie; Fuentes, Nora;
Fukuda, Masahiro; Gaborieau, Valérie; Gaci, Rostane; Gagliardi, Massimo; Gagnard, JeanCharles; Gagné , Nathalie; Gagneux-Brunon, Amandine; Gaião, Sérgio; Gail Skeie, Linda;
Gallagher, Phil; Gallego Curto, Elena; Gamble, Carrol; Gani, Yasmin; Garan, Arthur; Garcia,
Rebekha; García Barrio, Noelia; Garcia-Gallo, Esteban; Garimella, Navya; Garot, Denis; Garrait,
Valérie; Gault, Nathalie; Gavin, Aisling; Gavrilov, Anatoliy; Gaymard, Alexandre; Gebauer,
Johanes; Geraud, Eva; Gerbaud Morlaes, Louis; Germano, Nuno; Ghosn, Jade; Giani, Marco;
Giaquinto, Carlo; Gibson, Jess; Gigante, Tristan; Gilg, Morgane; Giordano, Guillermo; Girvan,
Michelle; Gissot, Valérie; Giwangkancana, Gezy; Glikman, Daniel; Glybochko, Petr; Gnall, Eric;
Goco, Geraldine; Goehringer, François; Goepel, Siri; Goffard, Jean-Christophe; Goh, Jin Yi;
Golob, Jonathan; Gomes, Rui; Gómez-Junyent, Joan; Gominet, Marie; Gonzalez Gonzalez,
Alicia; Gorenne, Isabelle; Goubert, Laure; Goujard, Cécile; Goulenok, Tiphaine; Grable,
Margarite; Graf, Jeronimo; Grandin, Edward Wilson; Granier, Pascal; Grasselli, Giacomo;
Grazioli, Lorenzo; Green, Christopher A.; Greenhalf, William; Greffe, Segolène; Grieco,
Domenico Luca; Griffee, Matthew; Griffiths, Fiona; Grigoras, Ioana; Groenendijk, Albert;
Grosse Lordemann, Anja; Gruner, Heidi; Gu, Yusing; Guarracino, Fabio; Guedj, Jérémie;
Guego, Martin; Guellec, Dewi; Guerguerian, Anne-Marie; Guerreiro, Daniela; Guery, Romain;
Guillaumot, Anne; Guilleminault, Laurent; Guimard, Thomas; Haalboom, Marieke; Haber,
Daniel; Hachemi, Ali; Hadri, Nadir; Haidash, Olena; Hakak, Sheeba; Hall, Adam; Hall, Matthew;
Halpin, Sophie; Hamer, Ansley; Hamidfar, Rebecca; Hammond, Terese; Han, Lim Yuen;
Haniffa, Rashan; Hao, Kok Wei; Hardwick, Hayley; Harley, Kristen; Harrison, Ewen M.;
Harrison, Janet; Harrison, Samuel Bernard Ekow; Hashmi, Madiha; Hayat, Muhammad; Hays,
Leanne; Heerman, Jan; Heggelund, Lars; Hendry, Ross; Hennessy, Martina; Henriquez,
Aquiles; Hentzien, Maxime; Herekar, Fivzia; Hernandez-Montfort, Jaime; Herr, Daniel;
Hershey, Andrew; Hesstvedt, Liv; Hidaya, Astarini; Higgins, Dawn; Higgins, Eibhilin; Hing,
Nickolas; Hinton, Samuel; Hipólito-Reis, Ana; Hiraiwa, Hiroaki; Hirkani, Haider; Hitoto,
Hikombo; Ho, Antonia Ying Wai; Ho, Yi Bin; Hoctin, Alexandre; Hoffmann, Isabelle; Hoh, Wei
Han; Hoiting, Oscar; Holt, Rebecca; Holter, Jan Cato; Horby, Peter; Horcajada, Juan Pablo;
Hoshino, Koji; Hoshino, Kota; Houas, Ikram; Hough, Catherine L.; Hsu, Jimmy Ming-Yang;
Hulot, Jean-Sébastien; Ijaz, Samreen; Illes, Hajnal-Gabriela; Imbert, Patrick; Inácio, Hugo;
Infante Dominguez, Carmen; Ing, Yun Sii; Iosifidis, Elias; Ippolito, Mariachiara; Irvine, Lacey;
Isgett, Sarah; Ishani, Palliya Guruge Pramodya Ishani; Isidoro, Tiago; Ismail, Nadiah; Isnard,
Margaux; Itai, Junji; Ivulich, Daniel; Jaafar, Danielle; Jaafoura, Salma; Jabot, Julien; Jackson,
Clare; Jacquet, Pierre; Jamieson, Nina; Jassat, Waasila; Jaud-Fischer, Coline; Jaureguiberry,
Stéphane; Javidfar, Jeffrey; Jawad, Issrah; Jayakumar, Devachandran; Jego, Florence; Jelani,
Anilawati Mat; Jenum, Synne; Jimbo-Sotomayor, Ruth; Joe, Ong Yiaw; Jorge García, Ruth N.;
Joseph, Cédric; Joseph, Mark; Joshi, Swosti; Jourdain, Mercé; Jouvet, Philippe; jung, anna;
Jung, Hanna; Juzar, Dafsah; Kafif, Ouifiya; Kaguelidou, Florentia; Kaisbain, Neerusha;
Kaleesvran, Thavamany; Kali, Sabina; Kalomoiri, Smaragdi; Kamal, Saima; Kamaluddin,
Muhammad Aisar Ayadi; Kamaruddin, Zul Amali Che; Kamarudin, Nadiah; Kambiya, Paul;
Kandamby, Darshana Hewa; Kandel, Chris; Kang, Kong Yeow; Kant, Ravi; Kanyawati, Dyah;
Karpayah, Pratap; Karsies, Todd; Kartsonaki, Christiana; Kasugai, Daisuke; Kataria, Anant;
Katz, Kevin; Kaur Johal, Simreen; Kawasaki, Tatsuya; Kay, Christy; Keating, Sean; Kedia, Pulak;
Kelly, Andrea; Kelly, Sadie; Kennedy, Lisa; Kennedy, Ryan; Kennon, Kalynn; Kerroumi, Younes;

medRxiv preprint doi: https://doi.org/10.1101/2020.07.17.20155218; this version posted April 16, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

Kestelyn, Evelyne; Khalid, Imrana; Khalid, Osama; Khalil, Antoine; Khan, Coralie; Khan, Irfan;
Khanal, Sushil; Kherajani, Krish; Kho, Michelle E; Khoo, Denisa; Khoo, Ryan; Khoo, Saye; Khoso,
Nasir; Kiat, Khor How; Kida, Yuri; Kiiza, Peter; Kildal, Anders Benjamin; Kim, Jae Burm;
Kimmoun, Antoine; Kindgen-Milles, Detlef; Kitamura, Nobuya; Klenerman, Paul; Kloumann
Bekken, Gry; Knight, Stephen; Kobbe, Robin; Kodippily, Chamira; Kohns Vasconcelos, Malte;
Koirala, Sabin; Komatsu, Mamoru; Korten, Volkan; Kosgei, Caroline; Kpangon, Arsène;
Krawczyk, Karolina; Krishnan, Vinothini; Kruglova, Oksana; Kumar, Ashok; Kumar, Deepali;
Kumar, Ganesh; Kumar, Mukesh; Kumar Tirupakuzhi Vijayaraghavan, Bharath; Kumar
Vecham, Pavan; Kurtzman, Ethan; Kusumastuti, Neurinda Permata; Kutsogiannis, Demetrios;
Kutsyna, Galyna; Kyriakoulis, Konstantinos; L'Her, Erwan; Lachatre, Marie; Lacoste, Marie;
Laffey, John G; Lagrange, Marie; Laine, Fabrice; Lairez, Olivier; Lalueza Blanco, Antonio;
Lambert, Marc; Lamontagne, François; Langelot-Richard, Marie; Langlois, Vincent; Lantang,
Eka Yudha; Lanza, Marina; Laouénan, Cédric; Laribi, Samira; Lariviere, Delphine; Lasry,
Stéphane; Lath, Sakshi; Launay, Odile; Laureillard, Didier; Lavie-Badie, Yoan; Law, Andrew;
Lawrence, Cassie; Le, Minh; Le Bihan, Clément; Le Bris, Cyril; Le Falher, Georges; Le Fevre,
Lucie; Le Hingrat, Quentin; Le Maréchal, Marion; Le Mestre, Soizic; Le Moal, Gwenaël; Le
Moing, Vincent; Le Nagard, Hervé; Le Turnier, Paul; Leal, Ema; Leal Santos, Marta; Lee, Biing
Horng; Lee, Heng Gee; Lee, James; Lee, Su Hwan; Lee, Todd C.; Lee, Yi Lin; Leeming, Gary;
Lefebvre, Bénédicte; Lefebvre, Laurent; Lefevre, Benjamin; LeGac, Sylvie; Lelievre, JeanDaniel; Lellouche, François; Lemaignen, Adrien; Lemee, Véronique; Lemeur, Anthony;
Lemmink, Gretchen; Lene, Ha Sha; León, Rafael; Leone, Marc; Leone, Michela; Lepiller,
Quentin; Lescure, François-Xavier; Lesens, Olivier; Lesouhaitier, Mathieu; Levy, Bruno; Levy,
Yves; Levy-Marchal, Claire; Lewandowska, Katarzyna; Li Bassi, Gianluigi; Liang, Janet; Liaquat,
Ali; Liegeon, Geoffrey; Lim, Kah Chuan; Lim, Wei Shen; Lima, Chantre; Lina, Bruno; Lina, Lim;
Lind, Andreas; Lingas, Guillaume; Link, Linda; Lion-Daolio, Sylvie; Lissauer, Samantha; Liu,
Keibun; Livrozet, Marine; Loforte, Antonio; Lolong, Navy; Loon, Leong Chee; Lopes, Diogo;
Lopez-Colon, Dalia; Loubet, Paul; Loufti, Bouchra; Louis, Guillame; Lourenco, Silvia; LovelaceMacon, Lara; Low, Lee Lee; Loy, Jia Shyi; Lucet, Jean Christophe; Lumbreras Bermejo, Carlos;
Luna, Carlos M.; Lungu, Olguta; Luong, Liem; LUQUE, NESTOR; Luton, Dominique; Lwin, Nilar;
Lyons, Ruth; Maasikas, Olavi; Mabiala, Oryane; MacDonald, Samual; MacDonald, Sarah;
Machado, Moïse; Macheda, Gabriel; Macias Sanchez, Juan; Madhok, Jai; Maestro de la Calle,
Guillermo; Mahieu, Rafael; Mahy, Sophie; Maia, Ana Raquel; Maier, Lars Siegfrid; Maillet,
Mylène; Maitre, Thomas; Malfertheiner, Maximilian; Malik, Nadia; Maltez, Fernando; Malvy,
Denis; Manda, Victoria; Mandei, Jose M.; Mandelbrot, Laurent; Mankikian, Julie; Manning,
Edmund; Manuel, Aldric; Maria Sant`Ana Malaque, Ceila; Marino, Daniel; Marino, Flávio;
Mariz, Carolline de Araújo; Markowicz, Samuel; Maroun Eid, Charbel; Marques, Ana; Marquis,
Catherine; Marsh, Brian; Marshall, John; Martelli, Celina Turchi; Martin, Dori-Ann; Martin,
Emily; Martin-Blondel, Guillaume; Martin-Loeches, Ignacio; Martin-Quiros, Alejandro;
Martinelli, Alessandra; Martinot, Martin; Martins, Ana; Martins, João; Martins, Nuno; Martins
Rego, Caroline; Martucci, Gennaro; Martynenko, Olga; Marwali, Eva Miranda; Marzukie,
Marsilla; Masa Jimenez, Juan Fernado; Maslove, David; Mason, Phillip; Mason, Sabina; Mat
Nor, Basri; Matan, Moshe; Mathieu, Daniel; Mattei, Mathieu; Matulevics, Romans; Maulin,
Laurence; May, Jennifer; Maynar, Javier; Mazzoni, Thierry; Mc Evoy, Natalie; McArthur, Colin;
McCarthy, Aine; McCarthy, Anne; McCloskey, Colin; McConnochie, Rachael; McDermott,
Sherry; McDonald, Sarah; McElwee, Samuel; McGeer, Allison; McGuinness, Niki; McKay,
Chris; McKeown, Johnny; McLean, Kenneth A.; McNicholas, Bairbre; Meaney, Edel; MearPassard, Cécile; Mechlin, Maggie; Meher, Maqsood; Mehkri, Omar; Mele, Ferruccio; Melo,

medRxiv preprint doi: https://doi.org/10.1101/2020.07.17.20155218; this version posted April 16, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

Luis; Memon, Kashif; Mendes, Joao Joao; Menkiti, Ogechukwu; Menon, Kusum; Mentré,
France; Mentzer, Alexander J.; Mercier, Emmanuelle; Mercier, Noémie; Merckx, Antoine;
Mergeay-Fabre, Mayka; Mergler, Blake; Merson, Laura; Mesquita, António; Meybeck, Agnès;
Meyer, Dan; Meynert, Alison M.; Meysonnier, Vanina; Meziane, Amina; Mezidi, Mehdi;
Michelagnoli, Giuliano; Michelanglei, Céline; Michelet, Isabelle; Mihelis, Efstathia; Mihnovitš,
Vladislav; Miranda-Maldonado, Hugo; Misnan, Nor Arisah; Mohamed, Nik Nur Eliza;
Mohamed, Tahira Jamal; Moin, Asma; Molina, David; Molinos, Elena; Mone, Mary; Monteiro,
Agostinho; Montes, Claudia; Montrucchio, Giorgia; Moore, Sarah; Moore, Shona C.; Morales
Cely, Lina; Moro, Lucia; Morocho, Diego; Morton, Ben; Motherway, Catherine; Motos, Ana;
Mouquet, Hugo; Mouton Perrot, Clara; Moyet, Julien; Mudara, Caroline; Muh, Ng Yong;
Muhamad, Dzawani; Mullaert, Jimmy; Müller, Fredrik; Müller, Karl Erik; Munblit, Daniel;
Muneeb, Syed; Murris, Marlène; Murthy, Srinivas; Muyandy, Gugapriyaa; Myrodia, Dimitra
Melia; Nagpal, Dave; Nagrebetsky, Alex; Narasimhan, Mangala; Nasim Khan, Rashid; Neant,
Nadège; Neb, Holger; Nekliudov, Nikita A; Neto, Raul; Neumann, Emily; Neves, Bernardo; Ng,
Pauline Yeung; Ng, Wing Yiu; Nghi, Anthony; Nguyen, Duc; Ni Choileain, Orna; Nichol, Alistair;
Nonas, Stephanie; Noordin, Nurul Amani Mohd; Noret, Marion; Norharizam, Nurul Faten
Izzati; Norman, Lisa; Notari, Alessandra; Noursadeghi, Mahdad; Nowicka, Karolina; Nowiński,
Adam; Nseir, Saad; Nunez, Jose I; Nurnaningsih, Nurnaningsih; Nyamankolly, Elsa; O'Donnell,
Max; O'Hearn, Katie; O'Neil, Conar; Occhipinti, Giovanna; Ogston, Tawnya; Ogura, Takayuki;
Oh, Tak-Hyuk; Ohshimo, Shinichiro; Oinam, Budhacharan Singh; Oliveira, João; Oliveira,
Larissa; Olliaro, Piero L.; Ong, David S.Y.; Ong, Jee Yan; Oosthuyzen, Wilna; Opavsky, Anne;
Openshaw, Peter; Orakzai, Saijad; Orozco-Chamorro, Claudia Milena; Orquera, Andrés;
Ortoleva, Jamel; Osatnik, Javier; Othman, Siti Zubaidah; Ouamara, Nadia; Ouissa, Rachida;
Owyang, Clark; Oziol, Eric; Pabasara, H M Upulee; Pagadoy, Maïder; Pages, Justine; Palacios,
Amanda; Palacios, Mario; Palmarini, Massimo; Panarello, Giovanna; Panda, Prasan Kumar;
Paneru, Hem; Pang, Lai Hui; Panigada, Mauro; Pansu, Nathalie; Papadopoulos, Aurélie; Parke,
Rachael; Parker, Melissa; Parra, Briseida; Parrini, Vieri; Pasha, Taha; Pasquier, Jérémie;
Pastene, Bruno; Patauner, Fabian; Patel, Drashti; Patel, Junaid; Pathmanathan, Mohan Dass;
Patrão, Luís; Patricio, Patricia; Patrier, Juliette; Patterson, Lisa; Pattnaik, Rajyabardhan; Paul,
Christelle; Paul, Mical; Paulos, Jorge; Paxton, William A.; Payen, Jean-François; Peariasamy,
Kalaiarasu; Pearse, India; Pedrera Jiménez, Miguel; Peek, Giles; Peelman, Florent; PeifferSmadja, Nathan; Peigne, Vincent; Pejkovska, Mare; Pelosi, Paolo; Peltan, Ithan D.; Pereira,
Rui; Perez, Daniel; Periel, Luis; Perpoint, Thomas; Pesenti, Antonio; Pestre, Vincent;
Petroušová, Lenka; Petrov-Sanchez, Ventzislava; Pettersen, Frank Olav; Peytavin, Gilles;
Pharand, Scott; Piagnerelli, Michael; Picard, Walter; Picone, Olivier; Piero, Maria de; Pierobon,
Carola; Pimentel, Carlos; Pinto, Raquel; Pirathayini, Vicknesha; Pironneau, Isabelle; Piroth,
Lionel; Pius, Riinu; Piva, Simone; Plantier, Laurent; Plotkin, Daniel; Png, Hon Shen; Poissy,
Julien; Pokeerbux, Ryadh; Pokorska-Śpiewak, Maria; Poli, Sergio; Pollakis, Georgios;
Ponscarme, Diane; Popielska, Jolanta; Post, Andra-Maris; Postma, Douwe F.; Povoa, Pedro;
Póvoas, Diana; Powis, Jeff; Prapa, Sofia; Preau, Sébastien; Prebensen, Christian; Preiser, JeanCharles; Prinssen, Anton; Pritchard, Mark; Priyadarshani, Gamage Dona Dilanthi; Proença,
Lúcia; Prompak, N; Puéchal, Oriane; Pujo Semedi, Bambang; Pulicken, Mathew; Purcell,
Gregory; Quesada, Luisa; Quinones-Cardona, Vilmaris; Quirós González, Víctor; QuistPaulsen, Else; Quraishi, Mohammed; Rabaud, Christian; Rafael, Aldo; Rafiq, Marie; Ragazzo,
Gabrielle; Rahman, Ahmad Kashfi Haji Ab; Rahman, Rozanah Abd; Rahutullah, Arsalan;
Rainieri, Fernando; Rajahram, Giri Shan; Ralib, Azrina; Ramakrishnan, Nagarajan;
Ramanathan, Kollengode; Ramli, Ahmad Afiq; Rammaert, Blandine; Ramos, Grazielle Viana;

medRxiv preprint doi: https://doi.org/10.1101/2020.07.17.20155218; this version posted April 16, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

Rana, Asim; Rapp, Christophe; Rashan, Aasiyah; Rashan, Thalha; Rasmin, Menaldi; Rätsep,
Indrek; Rau, Cornelius; Ravi, Tharmini; Raza, Ali; Real, Andre; Rebaudet, Stanislas; Redl, Sarah;
Reeve, Brenda; Rehan, Ali; Rehman, Attaur; Reid, Liadain; Reikvam, Dag Henrik; Reis, Renato;
Rello, Jordi; Remppis, Jonathan; Remy, Martine; Ren, Hongru; Renk, Hanna; Resende, Liliana;
Resseguier, Anne-Sophie; Revest, Matthieu; Rewa, Oleksa; Reyes, Luis F.; Reyes, Tiago;
Ribeiro, Maria Ines; Richardson, David; Richardson, Denise; Richier, Laurent; Ridzuan, Siti
Nurul Atikah Ahmad; Riera, Jordi; Rios, Ana Lúcia; Rishu, Asgar; Rispal, Patrick; Risso, Karine;
Rivera Nuñez, Maria Angelica; Rizer, Nicholas; Robb, Doug; Robba, Chiara; Roberto, André;
Robertson, David L.; Robineau, Olivier; Roche-Campo, Ferran; Rodari, Paola; Rodeia, Simão;
Rodriguez Abreu, Julia; Roger, Claire; Roger, Pierre-Marie; Roilides, Emmanuel; Rojek,
Amanda; Romaru, Juliette; Roncon-Albuquerque Jr, Roberto; Roriz, Mélanie; Rosa-Calatrava,
Manuel; Rose, Michael; Rosenberger, Dorothea; Roslan, Nurul Hidayah Mohammad;
Rossanese, Andrea; Rossetti, Matteo; Rossignol, Bénédicte; Rossignol, Patrick; Rössler,
Bernhard; Rousset, Stella; Roy, Carine; Roze, Benoît; Rusmawatiningtyas, Desy; Russell, Clark
D.; Ryckaert, Steffi; Rygh Holten, Aleksander; Saba, Isabela; Sadaf, Sairah; Sadat, Musharaf;
Sahraei, Valla; Saint-Gilles, Maximilien; Sakiyalak, Pranya; Salahuddin, Nawal; Salazar,
Leonardo; Sales, Gabriele; Sallaberry, Stéphane; Salmon Gandonniere, Charlotte; Salvator,
Hélène; Sanchez, Angel; Sanchez, Olivier; Sánchez Choez, Xavier; Sancho-Shimizu, Vanessa;
Sandhu, Gyan; Sandrine, Pierre-François; Sandulescu, Oana; Santos, Marlene; Sarfo-Mensah,
Shirley; Sarmiento, Iam Claire E.; Sarton, Benjamine; Satya, Ankana; Satyapriya, Sree;
satyawati, Rumaisah; Savvidou, Parthena; Saw, Yen Tsen; Scarsbrook, Joshua; Schaffer, Justin;
Schermer, Tjard; Scherpereel, Arnaud; Schneider, Marion; Schroll, Stephan; Schwameis,
Michael; Scott, Janet T.; Scott-Brown, James; Sedillot, Nicholas; Seitz, Tamara; Selvanayagam,
Jaganathan; Selvarajoo, Mageswari; Semaille, Caroline; Semple, Malcolm G.; Senian, Rasidah
Bt; Senneville, Eric; Sepulveda, Claudia; Sequeira, Filipa; Sequeira, Tânia; Serpa Neto, Ary;
Serrano Balazote, Pablo; Shadowitz, Ellen; Shahidan, Syamin Asyraf; Shamsah, Mohammad;
Sharma, Pratima; Shaw, Catherine A.; Shaw, Victoria; Sheharyar, Ashraf; Shetty, Rohan; Shi,
Haixia; Shiban, Nisreen; Shiekh, Mohiuddin; Shiga, Takuya; Shime, Nobuaki; Shimizu, Hiroaki;
Shimizu, Keiki; Shimizu, Naoki; Shrapnel, Sally; Shuker, Tristan; Shum, Hoi Ping; Si
Mohammed, Nassima; Siang, Ng Yong; Sibiude, Jeanne; Siddiqui, Atif; Sigfrid, Louise; Sillaots,
Piret; Silva, Catarina; Silva, Maria Joao; Silva, Rogério; Sim Lim Heng, Benedict; Sin, Wai Ching;
Sitompul, Pompini Agustina; Sivam, Karisha; Skogen, Vegard; Smith, Sue; Smood, Benjamin;
Smyth, Michelle; Snacken, Morgane; So, Dominic; Soh, Tze Vee; Solis, Monserrat; Solomon,
Joshua; Solomon, Tom; Somers, Emily; Sommet, Agnès; Song, Myung Jin; Song, Rima; Song,
Tae; Sonntagbauer, Michael; Soom, Azlan Mat; Sotto, Alberto; Soum, Edouard; Sousa, Ana
Chora; Sousa, Marta; Sousa Uva, Maria; Souza-Dantas, Vicente; Sperry, Alexandra; Sri
Darshana, B. P. Sanka Ruwan; Sriskandan, Shiranee; Stabler, Sarah; Staudinger, Thomas;
Stecher, Stepanie-Susanne; Steinsvik, Trude; Stienstra, Ymkje; Stiksrud, Birgitte; StreinuCercel, Adrian; Streinu-Cercel, Anca; Strudwick, Samantha; Stuart, Ami; Stuart, David; Suen,
Gabriel; Suen, Jacky Y.; Sultana, Asfia; Summers, Charlotte; Suppiah, Deepashankari;
Surovcova, Magdalena; Svistunov, Andrey A; Syahrin, Sarah; Syrigos, Konstantinos; Sztajnbok,
Jaques; Szuldrzynski, Konstanty; Tabrizi, Shirin; Taccone, Fabio S.; Tagherset, Lysa; Taib,
Shahdattul Mawarni; Talarek, Ewa; Taleb, Sara; Talsma, Jelmer; Tampubolon, Maria
Lawrensia; Tan, Kim Keat; Tan, Le Van; Tan, Yan Chyi; Tanaka, Clarice; Tanaka, Hiroyuki;
Tanaka, Taku; Taniguchi, Hayato; Tanveer, Hussain; Tardivon, Coralie; Tattevin, Pierre; Taufik,
M Azhari; Tedder, Richard S.; Tee, Tze Yuan; Teixeira, João; Tejada, Sofia; Tellier, MarieCapucine; Teoh, Sze Kye; Teotonio, Vanessa; Téoulé, François; Terpstra, Pleun; Terrier, Olivier;

medRxiv preprint doi: https://doi.org/10.1101/2020.07.17.20155218; this version posted April 16, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

Terzi, Nicolas; Tessier-Grenier, Hubert; Thabit, Alif Adlan Mohd; Tham, Zhang Duan;
Thangavelu, Suvintheran; Thibault, Vincent; Thiberville, Simon-Djamel; Thill, Benoît;
Thirumanickam, Jananee; Tho, Leong Chin; Thompson, Shaun; Thomson, David; Thomson,
Emma C.; Thurai, Surain Raaj Thanga; Thuy, Duong Bich; Thwaites, Ryan S.; Tieroshyn, Vadim;
Timashev, Peter S; Timsit, Jean-François; Tissot, Noémie; Toh, Jordan Zhien Yang; Toki, Maria;
Tolppa, Timo; Tonby, Kristian; Tonnii, Sia Loong; Torres, Antoni; Torres, Margarida; Torres
Santos-Olmo, Rosario Maria; Torres-Zevallos, Hernando; Trapani, Tony; Treoux, Théo; Trieu,
Huynh Trung; Tromeur, Cécile; Trontzas, Ioannis; Troost, Jonathan; Trouillon, Tiffany; Truong,
Jeanne; Tual, Christelle; Tubiana, Sarah; Tuite, Helen; Turmel, Jean-Marie; Turtle, Lance C.W.;
Tveita, Anders; Twardowski, Pawel; Uchiyama, Makoto; Udayanga, PG Ishara; Udy, Andrew;
Ullrich, Roman; Uribe, Alberto; Usman, Asad; Val-Flores, Luís; Valle, Ana Luiza; Valran, Amélie;
Van De Velde, Stijn; van den Berge, Marcel; Van der Feltz, Machteld; Van Der Vekens, Nicky;
Van der Voort, Peter; Van Der Werf, Sylvie; van Dyk, Marlice; van Gulik, Laura; Van Hattem,
Jarne; van Lelyveld, Steven; van Netten, Carolien; van Twillert, G; Vanel, Noémie;
Vanoverschelde, Henk; Vasudayan, Shoban Raj; Vauchy, Charline; Veeran, Shaminee;
Veislinger, Aurélie; Ventura, Sara; Verbon, Annelies; Vidal, José Ernesto; Vieira, César;
Villanueva, Joy Ann; Villar, Judit; Villeneuve, Pierre-Marc; Villoldo, Andrea; Vinh Chau, Nguyen
Van; Vishwanathan, Gayatri; Visseaux, Benoit; Visser, Hannah; Vitiello, Chiara; Vuorinen,
Aapeli; Vuotto, Fanny; Wahab, Suhaila Abdul; Wahid, Nadirah Abdul; Wan Muhd Shukeri,
Wan Fadzlina; Wang, Chih-Hsien; Wei, Jia; Weil, Katharina; Wen, Tan Pei; Wesselius, Sanne;
West, T. Eoin; Wham, Murray; Whelan, Bryan; White, Nicole; Wicky, Paul Henri; Wiedemann,
Aurélie; Wijaya, Surya Oto; Wille, Keith; Willems, Suzette; Williams, Virginie; Wils, Evert-Jan;
Wong, Calvin; Wong, Teck Fung; Wong, Xin Ci; Wong, Yew Sing; Xian, Gan Ee; Xian, Lim Saio;
Xuan, Kuan Pei; Xynogalas, Ioannis; Yacoub, Sophie; Yakop, Siti Rohani Binti Mohd; Yamazaki,
Masaki; Yazdanpanah, Yazdan; Yelnik, Cécile; Yeoh, Chian Hui; Yerkovich, Stephanie;
Yokoyama, Toshiki; Yonis, Hodane; Yuliarto, Saptadi; Zaaqoq, Akram; Zabbe, Marion;
Zacharowski, Kai; Zahid, Masliza; Zahran, Maram; Zaidan, Nor Zaila Binti; Zambon, Maria;
Zambrano, Miguel; Zanella, Alberto; Zawadka, Konrad; Zaynah, Nurul; Zayyad, Hiba; Zoufaly,
Alexander; Zucman, David.

